Status:
COMPLETED
Topiramate for the Treatment of Methamphetamine Dependence - 1
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Conditions:
Methamphetamine
Eligibility:
All Genders
18-99 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to assess the efficacy and safety of topiramate as compared to placebo in reducing methamphetamine use in subjects with methamphetamine dependence.
Eligibility Criteria
Inclusion
- Treatment seeking individuals as the time of the study
- Must be able to proved written informed consent
- Must have a body mass index greater than 18 kg/m(2)
- Must meet DSM-IV criteria for methamphetamine dependence
- Must currently be using methamphetamine as confirmed by a positive urine test over the past 14 days
- If female of child bearing potential, must agree to use birth control
Exclusion
- Please contact the site for more information
Key Trial Info
Start Date :
April 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2008
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT00345371
Start Date
April 1 2006
End Date
December 1 2008
Last Update
March 27 2017
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Matrix Institute on Addictions
Costa Mesa, California, United States, 92627
2
South Bay Treatment Center
San Diego, California, United States, 92105
3
Torrance Site
Torrance, California, United States, 90502
4
John A. Burns School of Medicine
Honolulu, Hawaii, United States, 96813